XML 139 R109.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financing arrangements - Debt Issuances and Acquisition-Related Financing (Details) - USD ($)
1 Months Ended 3 Months Ended
Oct. 31, 2023
Mar. 31, 2023
Dec. 31, 2023
Oct. 06, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes            
Debt Instrument [Line Items]            
Face amount   $ 24,000,000,000     $ 7,000,000,000 $ 5,000,000,000
Notes | 3.00% notes due 2029 (3.00% 2029 Notes)            
Debt Instrument [Line Items]            
Face amount         $ 750,000,000  
Interest rate, stated percentage     3.00%   3.00%  
Notes | 4.05% notes due 2029 (4.05% 2029 Notes)            
Debt Instrument [Line Items]            
Face amount         $ 1,250,000,000  
Interest rate, stated percentage     4.05%   4.05%  
Notes | 3.35% notes due 2032 (3.35% 2032 Notes)            
Debt Instrument [Line Items]            
Face amount         $ 1,000,000,000  
Interest rate, stated percentage     3.35%   3.35%  
Notes | 4.20% notes due 2033 (4.20% 2033 Notes)            
Debt Instrument [Line Items]            
Face amount         $ 750,000,000  
Interest rate, stated percentage     4.20%   4.20%  
Notes | 4.20% notes due 2052 (4.20% 2052 Notes)            
Debt Instrument [Line Items]            
Face amount         $ 1,000,000,000  
Interest rate, stated percentage     4.20%   4.20%  
Notes | 4.875% notes due 2053 (4.875% 2053 Notes)            
Debt Instrument [Line Items]            
Face amount         $ 1,000,000,000  
Interest rate, stated percentage     4.875%   4.875%  
Notes | 4.40% notes due 2062 (4.40% 2062 Notes)            
Debt Instrument [Line Items]            
Face amount         $ 1,250,000,000  
Interest rate, stated percentage     4.40%   4.40%  
Notes | 1.65% notes due in 2028 (1.65% 2028 Notes)            
Debt Instrument [Line Items]            
Face amount           $ 1,250,000,000
Interest rate, stated percentage     1.65%   1.65% 1.65%
Notes | 2.00% notes due 2032 (2.00% 2032 Notes)            
Debt Instrument [Line Items]            
Face amount           $ 1,250,000,000
Interest rate, stated percentage           2.00%
Notes | 2.80% notes due 2041 (2.80% 2041 Notes)            
Debt Instrument [Line Items]            
Face amount           $ 1,150,000,000
Interest rate, stated percentage           2.80%
Notes | 3.00% notes due 2052 (3.00% 2052 Notes)            
Debt Instrument [Line Items]            
Face amount           $ 1,350,000,000
Interest rate, stated percentage     3.00%   3.00% 3.00%
Variable Rate Component Three | term loan credit agreement | Secured Overnight Financing Rate (SOFR)            
Debt Instrument [Line Items]            
Basis spread on variable rate 1.225%          
Horizon Therapeutics            
Debt Instrument [Line Items]            
Bridge credit reduced amount         $ 24,500,000,000  
Term loan credit agreement, total amount         4,000,000,000  
Term loan credit agreement, total borrowed       $ 4,000,000,000    
Term loan credit agreement, due in April 2025       2,000,000,000    
Term loan credit agreement, due in October 2026       $ 2,000,000,000    
Term loan, outstanding         $ 0  
Horizon Therapeutics | Other Nonoperating Income (Expense)            
Debt Instrument [Line Items]            
Amortization of other deferred charges   $ 98,000,000